ERp57 is overexpressed in 73% of cervical cancers, especially in adenocarcinoma, and high expression indicates poor overall survival and high recurrence-free survival rates in adenocarcinoma patients 33, 34. Here, PDIA3 is linked to adenocarcinoma.